Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Extracellular vesicle-carried GTF2I from mesenchymal stem cells promotes the expression of tumor-suppressive FAT1 and inhibits stemness maintenance in thyroid carcinoma

This work suggests that GTF2I transferred by MSC-EVs confer antioncogenic effects through the FAT1/CDK4/FOXM1 axis and may be used as a promising biomarker for TC treatment.

September 24, 2025


September 25 2025

September 24 2025

September 23 2025

September 22 2025

September 21 2025

September 20 2025

September 19 2025

September 18 2025

September 17 2025

September 16 2025

September 15 2025

September 14 2025

September 13 2025

September 12 2025

September 11 2025